Calculus VCT plc, formerly known as Investec Structured Products Calculus VCT PLC, is a venture capital trust specializing in venture capital investments.

Calculus VCT plc

Calculus Capital is a company that offers EIS and VCT investment products, focusing on backing businesses across the fastest growing sectors of the UK economy including technology, healthcare and the environment.

Calculus Capital

Calculus specialises in creating and managing venture capital funds for individuals. Calculus is a pioneer in the tax-efficient industry having set up the UK’s first approved EIS fund in 1999. Through the Calculus EIS Fund, Calculus VCT and Calculus Knowledge EIS Fund - investors can access a diverse portfolio of innovative UK companies.

Important note: EIS and VCT investments are high risk and capital is at risk. Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future.

Calculus Capital is authorised and regulated by the Financial Conduct Authority.

Synpromics Ltd

Scancell

Yourgene Health

Epistem

Arecor

Money Dashboard

C4X Discovery

Avvio

Horizon Discovery

Human Race

Inspiresport

Cloud Trade

Collagen Solutions

I am very pleased to announce Calculus' takeover of Great Point Media’s film and television production finance business, Illium. Illium has solid potential as an ongoing business providing secured financing for film and TV productions. We look forward to working closely with producers and our shareholders. Thanks to our incredible Calculus team for all their hard work over many weeks to make this possible.

How can investors prepare for a new political landscape? Read our election response, by Director Matthew Moynes here ⬇ 

https://lnkd.in/emxv2awK

The first Calculus Knowledge Intensive EIS Fund has been successfully fully deployed in just 11 months, we now have an exciting and diverse portfolio of healthcare and technology companies. 

'We focus on those companies which are the ‘doers,’ the innovators, the experts and the game changers.'

Congratulations on your BAFTA nomination for Evacuation, Wonderhood Studios 🏆 
We are so proud of the calibre of companies within our entertainment portfolio and the award nominations are a very well deserved endorsement.

Yesterday marked International Day of Women and Girls in Science, a celebration of the women who are blazing ahead to tackle the world’s toughest health challenges and discovering new scientific innovations.

We want to take this opportunity to thank and celebrate the inspirational women driving progress and innovation in #STEM, here at the Arecor Group and around the world.

Hear from some of the brilliant women working at Arecor Group, including our CEO Sarah Howell, and what it means to be a part of a successful women-led and diverse company culture, inspiring the next generation of female scientists.

https://lnkd.in/eHAB_qET

#Arecor #WomenInScience and #GirlsInSTEM

Amazing to see the growth and development of Calculus Capital portfolio company Laverock Therapeutics.

Read more: https://lnkd.in/grGcupd4

	Feb '14	Feb '15	Feb '16	Feb '17	Feb '18	Feb '19	Feb '20	Feb '21	Feb '22	Feb '23	Mar '24
revenue	74K -	64K 13.51%	54K 15.63%	35K 35.19%	138K 294.29%	-806K 684.06%	-321K 60.17%	547K 270.40%	2.20M 302.74%	969K 56.01%	453.23K 53.23%
cost of revenue
gross profit	74K -	64K 13.51%	54K 15.63%	35K 35.19%	138K 294.29%	-806K 684.06%	-321K 60.17%	547K 270.40%	2.20M 302.74%	969K 56.01%	453.23K 53.23%
selling and marketing expenses											302.77K -
general and administrative expenses	77K -	79K 2.60%	70K 11.39%	21K 70%	307K 1,361.90%	221K 28.01%	239K 8.14%	267K 11.72%	258K 3.37%	321K 24.42%	644.31K 100.72%
selling general and administrative expenses	77K -	79K 2.60%	70K 11.39%	21K 70%	307K 1,361.90%	221K 28.01%	239K 8.14%	267K 11.72%	258K 3.37%	321K 24.42%	947.08K 195.04%
research and development expenses
other expenses	-11K -	42K 481.82%	57K 35.71%	-20K 135.09%	49K 345%
cost and expenses	118K -	121K 2.54%	127K 4.96%	65K 48.82%	356K 447.69%	221K 37.92%	239K 8.14%	267K 11.72%	258K 3.37%	321K 24.42%	947.08K 195.04%
operating expenses	118K -	121K 2.54%	127K 4.96%	65K 48.82%	356K 447.69%	221K 37.92%	239K 8.14%	267K 11.72%	258K 3.37%	321K 24.42%	947.08K 195.04%
interest expense				308K -
ebitda	-44K -	-57K 29.55%	-73K 28.07%	-338K 363.01%	-273K 19.23%	-1.03M 276.19%	-560K 45.47%	280K 150%	1.95M 594.64%	648K 66.68%
operating income	-44K -	-57K 29.55%	-73K 28.07%	-30K 58.90%	-273K 810%	-1.03M 276.19%	-560K 45.47%	280K 150%	1.95M 594.64%	648K 66.68%	-493.85K 176.21%
depreciation and amortization				-308K -		1.03M -	556K 45.86%	-284K 151.08%			493.85K -
total other income expenses net				-308K -			-4K -	-4K 0%
income before tax	-44K -	-57K 29.55%	-73K 28.07%	-30K 58.90%	-273K 810%	-1.03M 276.19%	-560K 45.47%	280K 150%	1.95M 594.64%	648K 66.68%	-493.85K 176.21%
income tax expense				308K -		-1.03M -	-560K 45.47%	280K 150%
net income	-44K -	-57K 29.55%	-73K 28.07%	-30K 58.90%	-273K 810%	-1.03M 276.19%	-560K 45.47%	280K 150%	1.95M 594.64%	648K 66.68%	-493.85K 176.21%
weighted average shs out	4.74M -	4.74M 0%	4.74M 0%	4.74M 0%	10.03M 111.75%	14.13M 40.82%	21.73M 53.78%	28.74M 32.25%	40.34M 40.38%	49.89M 23.67%	60.24M 20.75%
weighted average shs out dil	4.74M -	4.74M 0%	4.74M 0%	4.74M 0%	10.03M 111.75%	14.13M 40.82%	21.73M 53.78%	28.74M 32.25%	40.34M 40.38%	49.89M 23.67%	60.24M 20.75%
eps	-0.01 -	-0.01 29.03%	-0.02 28.33%	-0.01 59.09%	-0.03 331.75%	-0.07 167.28%	-0.03 64.51%	0.01 137.98%	0.05 392.86%	0.01 73.08%	-0.01 163.08%
epsdiluted	-0.01 -	-0.01 29.03%	-0.02 28.33%	-0.01 59.09%	-0.03 331.75%	-0.07 167.28%	-0.03 64.51%	0.01 137.98%	0.05 392.86%	0.01 73.08%	-0.01 163.08%

COM:CALCULUSCAPITAL

Calculus Capital

Last Close

58.00

21/10 13:32

Market Cap

407.19K

Beta: -

Volume Today

29.96K

Avg: -

Preview